Published by Coherent Market Insights
Posted on September 27, 2021
“The Epistaxis Market 2021 – 2027 report covers the important factors driving the growth of the market, untapped opportunities for manufacturers, trends and developments shaping the dynamics of the market and other insights across various key segments.”
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/771
Epistaxis, also known as Perleche, occurs when a small amount of blood in the nasal cavities (the mucous membrane that protects the sensitive membranes of the nose) forms a crust on the back of the tongue, which blocks the tip of the nose and causes a nosebleed. Epistaxis can cause bleeding or nosebleeds, especially if there is not enough blood flow through the blocked area, which inflates and deflates to provide immediate nosebleed relief. The most affected areas are the soft palate (the area behind the front teeth), the ethmoid region of the nose, and the conjunctiva.
North America is expected to dominate the global market in the near future and this is accredited to the high prevalence of hypertension in the region. According to the U.S. Department of Health & Human Services, Nearly half of adults in the United States (108 million, or 45%) have hypertension defined as a systolic blood pressure ≥ 130 mm Hg or a diastolic blood pressure ≥ of 80 mm Hg or are taking medication for hypertension. Hypertension is one of the major causes of nose bleeding.
The increasing prevalence of nose bleeding due to dry climate and lack of humidity in the atmosphere is significantly propelling the growth of the epistaxis market. According to the National Center for Biotechnology Information, about 60% of people have experienced a nosebleed during their life, and only 10% of nosebleeds are severe enough to warrant treatment/medical intervention. They occur most commonly in children ranging from 2 to 10 years old and the elderly ranging from 50 to 80 years old. Moreover, the growing incidence of the heart-related disorder is leading to hypertension which is also one of the causes of nose bleeding, thereby propelling the growth of the epistaxis market. According to the World Health Organization, an estimated 1.13 billion people worldwide have hypertension, most (two-thirds) living in low- and middle-income countries.
Key Developments:
In September 2017, Optinose, an ENT / Allergy specialty pharmaceutical company, announced that the U.S. Food & Drug Administration (FDA) approved the Company’s New Drug Application (NDA) for XHANCE (previously referred to by the development name OPN-375) for the treatment of nasal polyps in patients 18 years of age and older
In June 2019, The U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis
Top Key Players Include In Epistaxis Market: Smith & Nephew, Medline Industries, Inc., Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceuticals, Inc.
The Epistaxis Market is displayed in 13 Chapters:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities
Chapter 2: Market Competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Epistaxis Research Findings and Conclusion, Appendix, methodology and data source
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/771
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Visit Our Blog For More Such Reports: https://www.coherentmarketinsights.com/blog
The post Epistaxis Market Research Report 2021 – Detailed Analysis of Future Trends & Growth Opportunities appeared first on Gatorledger.
“The Epistaxis Market 2021 – 2027 report covers the important factors driving the growth of the market, untapped opportunities for manufacturers, trends and developments shaping the dynamics of the market and other insights across various key segments.”
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/771
Epistaxis, also known as Perleche, occurs when a small amount of blood in the nasal cavities (the mucous membrane that protects the sensitive membranes of the nose) forms a crust on the back of the tongue, which blocks the tip of the nose and causes a nosebleed. Epistaxis can cause bleeding or nosebleeds, especially if there is not enough blood flow through the blocked area, which inflates and deflates to provide immediate nosebleed relief. The most affected areas are the soft palate (the area behind the front teeth), the ethmoid region of the nose, and the conjunctiva.
North America is expected to dominate the global market in the near future and this is accredited to the high prevalence of hypertension in the region. According to the U.S. Department of Health & Human Services, Nearly half of adults in the United States (108 million, or 45%) have hypertension defined as a systolic blood pressure ≥ 130 mm Hg or a diastolic blood pressure ≥ of 80 mm Hg or are taking medication for hypertension. Hypertension is one of the major causes of nose bleeding.
The increasing prevalence of nose bleeding due to dry climate and lack of humidity in the atmosphere is significantly propelling the growth of the epistaxis market. According to the National Center for Biotechnology Information, about 60% of people have experienced a nosebleed during their life, and only 10% of nosebleeds are severe enough to warrant treatment/medical intervention. They occur most commonly in children ranging from 2 to 10 years old and the elderly ranging from 50 to 80 years old. Moreover, the growing incidence of the heart-related disorder is leading to hypertension which is also one of the causes of nose bleeding, thereby propelling the growth of the epistaxis market. According to the World Health Organization, an estimated 1.13 billion people worldwide have hypertension, most (two-thirds) living in low- and middle-income countries.
Key Developments:
In September 2017, Optinose, an ENT / Allergy specialty pharmaceutical company, announced that the U.S. Food & Drug Administration (FDA) approved the Company’s New Drug Application (NDA) for XHANCE (previously referred to by the development name OPN-375) for the treatment of nasal polyps in patients 18 years of age and older
In June 2019, The U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis
Top Key Players Include In Epistaxis Market: Smith & Nephew, Medline Industries, Inc., Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceuticals, Inc.
The Epistaxis Market is displayed in 13 Chapters:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities
Chapter 2: Market Competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Epistaxis Research Findings and Conclusion, Appendix, methodology and data source
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/771
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Visit Our Blog For More Such Reports: https://www.coherentmarketinsights.com/blog
The post Epistaxis Market Research Report 2021 – Detailed Analysis of Future Trends & Growth Opportunities appeared first on Gatorledger.
Explore more articles in the Research Reports category
